Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HemosIL von Willebrand Factor Antigen

K-Number: K223402 · 2022-12-09

Decision Date2022-12-09
Product CodeGGP
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

HemosIL von Willebrand Factor Antigen is a medical device manufactured by Instrumentation Laboratory CO. It received FDA 510(k) clearance on 2022-12-09 under approval number K223402. The device is classified under product code GGP. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HemosIL von Willebrand Factor Antigen?

HemosIL von Willebrand Factor Antigen is a medical device that received FDA 510(k) clearance on 2022-12-09. It is manufactured by Instrumentation Laboratory CO. The 510(k) number is K223402.

When was HemosIL von Willebrand Factor Antigen approved by the FDA?

HemosIL von Willebrand Factor Antigen received FDA 510(k) clearance on 2022-12-09, under approval number K223402.

What company makes HemosIL von Willebrand Factor Antigen?

HemosIL von Willebrand Factor Antigen is manufactured by Instrumentation Laboratory CO.

What is the FDA product code for HemosIL von Willebrand Factor Antigen?

The FDA product code for HemosIL von Willebrand Factor Antigen is GGP.

Related Clinical Trials

Other Devices by Instrumentation Laboratory CO

View all 26 devices →

Related Devices (Code: GGP)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.